Vynleads (VYND) Non Operating Interest Expenses (2020)

Vynleads' (VYND) quarterly Non Operating Interest Expenses came in at -$990.0 in Q4 2020, down 1494.37% on a QoQ basis from $71.0 in Q3 2020.

Vynleads (VYND) Non Operating Interest Expenses (2020) Analysis & Trends

Vynleads (VYND) has 1 years of Non Operating Interest Expenses data on file, last reported at -$990.0 in Q4 2020.

On a quarterly basis, Non Operating Interest Expenses changed N/A year-over-year to -$990.0 in Q4 2020; TTM through Dec 2020 was $895.0, a N/A change from a year earlier, with the FY2020 full-year figure at $895.0, changed N/A from the prior year.
Non Operating Interest Expenses for Q4 2020 stood at -$990.0, down from $71.0 in the prior quarter.
Over the last five years, Non Operating Interest Expenses for VYND reached as high as $1547.0 in Q2 2020 and fell as low as -$990.0 in Q4 2020.

#	Company	Market Cap	Enterprise Value	Gross Profit (Qtr)	Non Operating Interest Expenses (Qtr)
1	Veeva Systems	29.34 Bn	22.03 Bn	662.02 Mn	-
2	BrightSpring Health Services	13.49 Bn	12.59 Bn	482.22 Mn	-
3	Healthequity	7.96 Bn	7.70 Bn	256.31 Mn	-
4	10x Genomics	6.17 Bn	5.63 Bn	106.18 Mn	-
5	Hinge Health	6.02 Bn	5.70 Bn	154.23 Mn	-
6	MiniMed	4.19 Bn	3.89 Bn	480.00 Mn	-
7	Waystar Holding	4.14 Bn	4.07 Bn	216.84 Mn	-
8	Doximity	3.82 Bn	3.08 Bn	125.97 Mn	-
9	Privia Health	3.10 Bn	2.73 Bn	-	-
10	Vynleads	7.51 Mn	7.51 Mn	-2,028.00	-

Download Data